{"id":113024,"date":"2026-06-11T13:06:07","date_gmt":"2026-06-11T07:36:07","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=113024"},"modified":"2026-06-11T13:06:08","modified_gmt":"2026-06-11T07:36:08","slug":"dr-lal-pathlabs-stock-prediction-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/","title":{"rendered":"Dr Lal PathLabs Stock Prediction 2026: Expert Analysis, Forecast Scenarios and Full Stock Review"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Dr Lal PathLabs CMP: Rs 1,591.3 (2026). 52W High: Rs 1,771. 52W Low: Rs 1,272. Mkt Cap: Rs 26,690 Cr. P\/E: 50.3. Analyst Consensus: Rs 1775.<\/em><\/p>\n<p>The <a href=\"https:\/\/univest.in\/stocks\/lalpathlab\/dr-lal-pathlabs-ltd-share-price-today\">Dr Lal PathLabs<\/a> stock prediction for 2026 from leading brokerages covers a range reflecting sector dynamics, earnings trajectory and the macro environment. All estimates may or may not be achieved. Treat any Dr Lal PathLabs share price prediction as one data point and not as a guarantee of future performance.<\/p>\n<p>This article reviews every dimension of the Dr Lal PathLabs stock forecast analysts are tracking, including key drivers, bull and bear scenarios and the primary risks. Verify all figures with the latest brokerage reports before any investment decision.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=dr-lal-pathlabs-stk-pred\" target=\"_blank\" rel=\"noopener\">Click Here &#8211; Get Free Investment Predictions<\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#What_Analysts_Predict_for_Dr_Lal_PathLabs_Stock_in_2026\" title=\"What Analysts Predict for Dr Lal PathLabs Stock in 2026\">What Analysts Predict for Dr Lal PathLabs Stock in 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#Dr_Lal_PathLabs_Company_Overview\" title=\"Dr Lal PathLabs Company Overview\">Dr Lal PathLabs Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#Dr_Lal_PathLabs_Stock_Prediction_by_Time_Horizon\" title=\"Dr Lal PathLabs Stock Prediction by Time Horizon\">Dr Lal PathLabs Stock Prediction by Time Horizon<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#Short-Term_Dr_Lal_PathLabs_Stock_Prediction\" title=\"Short-Term Dr Lal PathLabs Stock Prediction\">Short-Term Dr Lal PathLabs Stock Prediction<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#12-Month_Dr_Lal_PathLabs_Stock_Prediction\" title=\"12-Month Dr Lal PathLabs Stock Prediction\">12-Month Dr Lal PathLabs Stock Prediction<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#Long-Term_Dr_Lal_PathLabs_Stock_Prediction\" title=\"Long-Term Dr Lal PathLabs Stock Prediction\">Long-Term Dr Lal PathLabs Stock Prediction<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#Dr_Lal_PathLabs_Stock_Forecast_Key_Factors\" title=\"Dr Lal PathLabs Stock Forecast: Key Factors\">Dr Lal PathLabs Stock Forecast: Key Factors<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#Bed_Addition_and_Occupancy\" title=\"Bed Addition and Occupancy\">Bed Addition and Occupancy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#Revenue_per_Occupied_Bed\" title=\"Revenue per Occupied Bed\">Revenue per Occupied Bed<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#EBITDA_Margin_Maturity\" title=\"EBITDA Margin Maturity\">EBITDA Margin Maturity<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#International_Patient_Revenue\" title=\"International Patient Revenue\">International Patient Revenue<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#Dr_Lal_PathLabs_Stock_Prediction_Bull_and_Bear_Scenarios\" title=\"Dr Lal PathLabs Stock Prediction: Bull and Bear Scenarios\">Dr Lal PathLabs Stock Prediction: Bull and Bear Scenarios<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#How_Analysts_Are_Reading_the_Dr_Lal_PathLabs_Stock_Story\" title=\"How Analysts Are Reading the Dr Lal PathLabs Stock Story\">How Analysts Are Reading the Dr Lal PathLabs Stock Story<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#Key_Risks_to_the_Dr_Lal_PathLabs_Stock_Prediction\" title=\"Key Risks to the Dr Lal PathLabs Stock Prediction\">Key Risks to the Dr Lal PathLabs Stock Prediction<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#New_Hospital_Ramp-Up_Costs\" title=\"New Hospital Ramp-Up Costs\">New Hospital Ramp-Up Costs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#Regulatory_and_Price_Cap_Risk\" title=\"Regulatory and Price Cap Risk\">Regulatory and Price Cap Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#Competition\" title=\"Competition\">Competition<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#Medical_Cost_Inflation\" title=\"Medical Cost Inflation\">Medical Cost Inflation<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#How_to_Monitor_the_Dr_Lal_PathLabs_Stock_Forecast\" title=\"How to Monitor the Dr Lal PathLabs Stock Forecast\">How to Monitor the Dr Lal PathLabs Stock Forecast<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#Frequently_Asked_Questions_on_Dr_Lal_PathLabs_Stock_Prediction_2026\" title=\"Frequently Asked Questions on Dr Lal PathLabs Stock Prediction 2026\">Frequently Asked Questions on Dr Lal PathLabs Stock Prediction 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#What_is_the_Dr_Lal_PathLabs_stock_prediction_for_2026\" title=\"What is the Dr Lal PathLabs stock prediction for 2026?\">What is the Dr Lal PathLabs stock prediction for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#Is_the_Dr_Lal_PathLabs_stock_prediction_bullish_or_bearish\" title=\"Is the Dr Lal PathLabs stock prediction bullish or bearish?\">Is the Dr Lal PathLabs stock prediction bullish or bearish?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#What_is_the_Dr_Lal_PathLabs_share_price_prediction_based_on_fundamentals\" title=\"What is the Dr Lal PathLabs share price prediction based on fundamentals?\">What is the Dr Lal PathLabs share price prediction based on fundamentals?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#What_is_the_long-term_Dr_Lal_PathLabs_stock_prediction\" title=\"What is the long-term Dr Lal PathLabs stock prediction?\">What is the long-term Dr Lal PathLabs stock prediction?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#What_are_the_key_risks_to_the_Dr_Lal_PathLabs_stock_prediction\" title=\"What are the key risks to the Dr Lal PathLabs stock prediction?\">What are the key risks to the Dr Lal PathLabs stock prediction?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#What_does_the_Dr_Lal_PathLabs_stock_forecast_say_for_2026\" title=\"What does the Dr Lal PathLabs stock forecast say for 2026?\">What does the Dr Lal PathLabs stock forecast say for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/dr-lal-pathlabs-stock-prediction-2026\/#Where_can_I_track_the_latest_Dr_Lal_PathLabs_stock_prediction\" title=\"Where can I track the latest Dr Lal PathLabs stock prediction?\">Where can I track the latest Dr Lal PathLabs stock prediction?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Analysts_Predict_for_Dr_Lal_PathLabs_Stock_in_2026\"><\/span><strong>What Analysts Predict for Dr Lal PathLabs Stock in 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Analyst consensus on the Dr Lal PathLabs stock prediction for 2026 is tracked by leading brokerages. The table below shows the latest available data from JM Financial and ICICI Securities. All figures are sourced from publicly available research and should be verified before publishing.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Brokerage<\/th>\n<th>Rating<\/th>\n<th>Dr Lal PathLabs Stock Prediction (Rs)<\/th>\n<th>Updated<\/th>\n<\/tr>\n<tr>\n<td>JM Financial<\/td>\n<td>Neutral<\/td>\n<td>Rs 1800<\/td>\n<td>2026<\/td>\n<\/tr>\n<tr>\n<td>ICICI Securities<\/td>\n<td>Neutral<\/td>\n<td>Rs 1750<\/td>\n<td>2026<\/td>\n<\/tr>\n<tr>\n<td>Analyst Consensus<\/td>\n<td>&#8212;<\/td>\n<td>Rs 1775<\/td>\n<td>2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The Dr Lal PathLabs stock prediction range reflects genuine difference of opinion on demand recovery, margin trajectory and sector headwinds. The implied upside in the Dr Lal PathLabs stock forecast from the current price of Rs 1,591.3 may or may not be realised by end of 2026.<\/p>\n<div style=\"background: #E8EAFF; border-radius: 14px; padding: 28px 32px 24px 32px; margin: 24px 0; font-family: -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,sans-serif; cursor: pointer; max-width: 100%; box-sizing: border-box;\">\n<p style=\"font-size: 20px; font-weight: bold; color: #0a0a23; margin: 0 0 12px 0; line-height: 1.3;\">3 Stocks Building Serious Momentum Right Now<\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">When <strong style=\"color: #0a0a23;\">Univest analysts<\/strong> identify high-conviction stock opportunities, <em>investors pay attention.<\/em><\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">Our research team has shortlisted the <strong style=\"color: #0a0a23;\">Top Stocks to Buy<\/strong> based on current market momentum, sector trends &amp; growth potential for 2026.<\/p>\n<ul style=\"margin: 0 0 16px 20px; padding: 0; color: #3a3a5c; font-size: 15px; line-height: 1.8;\">\n<li>Discover stocks investors are actively accumulating<\/li>\n<li>High-conviction opportunities backed by research<\/li>\n<li>Designed for the next phase of market growth<\/li>\n<\/ul>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 20px 0;\">Unlock the latest <a style=\"color: #3b7fff; font-weight: bold; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/payment?planType=ALL_PRO%20PLANS\" target=\"_blank\" rel=\"noopener\">Top Stock Picks<\/a> now on Univest<\/p>\n<p><a style=\"display: inline-block; background: #3B7FFF; color: #fff; font-size: 15px; font-weight: 600; padding: 13px 28px; border-radius: 50px; letter-spacing: 0.2px; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/payment?planType=ALL_PRO%20PLANS\" target=\"_blank\" rel=\"noopener\">See the Stocks \u2192<\/a><\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Dr_Lal_PathLabs_Company_Overview\"><\/span><strong>Dr Lal PathLabs Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Dr Lal PathLabs is a leading healthcare services provider operating hospitals, diagnostics or specialty facilities across India. The Dr Lal PathLabs stock prediction for 2026 reflects structural growth in healthcare demand and operating leverage from bed expansion.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>LALPATHLAB<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Healthcare Services and Hospitals<\/td>\n<\/tr>\n<tr>\n<td>CMP<\/td>\n<td>Rs 1,591.3 (2026)<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 1,771<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 1,272<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 26,690 Cr<\/td>\n<\/tr>\n<tr>\n<td>P\/E Ratio<\/td>\n<td>50.3<\/td>\n<\/tr>\n<tr>\n<td>Dr Lal PathLabs Stock Prediction Consensus (12M)<\/td>\n<td>Rs 1775<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Dr_Lal_PathLabs_Stock_Prediction_by_Time_Horizon\"><\/span><strong>Dr Lal PathLabs Stock Prediction by Time Horizon<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Analysts split the Dr Lal PathLabs share price prediction across time frames as near-term drivers differ materially from the long-term view.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Short-Term_Dr_Lal_PathLabs_Stock_Prediction\"><\/span><strong>Short-Term Dr Lal PathLabs Stock Prediction<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The near-term Dr Lal PathLabs stock forecast reflects current sentiment, sector news and upcoming earnings prints. Key support and resistance levels around Rs 1,591.3 are being watched closely. A short-term Dr Lal PathLabs share price prediction carries the most uncertainty of any time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"12-Month_Dr_Lal_PathLabs_Stock_Prediction\"><\/span><strong>12-Month Dr Lal PathLabs Stock Prediction<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>JM Financial targets Rs 1800 (Neutral) and ICICI Securities targets Rs 1750 (Neutral). Most desks refresh their Dr Lal PathLabs stock forecast within two to four weeks of each quarterly earnings print. The Dr Lal PathLabs share price prediction should be verified against the most recent analyst reports.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Long-Term_Dr_Lal_PathLabs_Stock_Prediction\"><\/span><strong>Long-Term Dr Lal PathLabs Stock Prediction<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The long-term Dr Lal PathLabs stock prediction is built on assumptions about demand recovery, margin expansion and revenue diversification in the Healthcare Services and Hospitals sector. The long-term Dr Lal PathLabs share price prediction carries the most uncertainty and should be treated as directional guidance only.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dr_Lal_PathLabs_Stock_Forecast_Key_Factors\"><\/span><strong>Dr Lal PathLabs Stock Forecast: Key Factors<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The following four factors appear consistently in research reports on the Dr Lal PathLabs stock prediction and are the primary inputs into the bull and bear case scenarios.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Bed_Addition_and_Occupancy\"><\/span><strong>Bed Addition and Occupancy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Hospital bed additions and occupancy rates are the primary metrics in the Dr Lal PathLabs stock forecast. Analysts look for occupancy above 65 percent as the basis for a higher Dr Lal PathLabs share price prediction.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_per_Occupied_Bed\"><\/span><strong>Revenue per Occupied Bed<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Revenue per occupied bed improvement reflects the shift to higher-margin specialties. Analysts revise the Dr Lal PathLabs share price prediction upward when per-bed revenue grows consistently.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"EBITDA_Margin_Maturity\"><\/span><strong>EBITDA Margin Maturity<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>A portfolio shift toward mature hospitals supports the bullish Dr Lal PathLabs stock prediction, while new hospital ramp-ups dilute margins in the near term.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"International_Patient_Revenue\"><\/span><strong>International Patient Revenue<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Medical tourism revenue provides premium pricing and diversifies the revenue base, supporting the Dr Lal PathLabs stock forecast and premium valuation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dr_Lal_PathLabs_Stock_Prediction_Bull_and_Bear_Scenarios\"><\/span><strong>Dr Lal PathLabs Stock Prediction: Bull and Bear Scenarios<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Dr Lal PathLabs Stock Prediction<\/th>\n<th>Key Conditions<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>Rs 1800<\/td>\n<td>Strong execution, margin improvement, favourable macro and sector re-rating<\/td>\n<\/tr>\n<tr>\n<td>Base Case<\/td>\n<td>Rs 1775<\/td>\n<td>Steady performance, gradual recovery, margins hold, growth on track<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 1272<\/td>\n<td>Demand deterioration, margin pressure, sector de-rating and macro headwinds<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The bull case Dr Lal PathLabs stock forecast of Rs 1800 assumes most positive variables converge. The base case of Rs 1775 is the analyst consensus and may or may not be achieved.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_Analysts_Are_Reading_the_Dr_Lal_PathLabs_Stock_Story\"><\/span><strong>How Analysts Are Reading the Dr Lal PathLabs Stock Story<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Analyst reviews of the Dr Lal PathLabs share price prediction highlight the company&#8217;s core strengths in Healthcare Services and Hospitals alongside near-term headwinds from macro uncertainty, competitive pressure and sector-level challenges. Overall the Dr Lal PathLabs stock prediction consensus is built on real business strengths set against real risks.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_the_Dr_Lal_PathLabs_Stock_Prediction\"><\/span><strong>Key Risks to the Dr Lal PathLabs Stock Prediction<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"New_Hospital_Ramp-Up_Costs\"><\/span><strong>New Hospital Ramp-Up Costs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>New hospital investments have multi-year ramp-up periods during which margins are diluted. This is a recurring near-term risk to the Dr Lal PathLabs stock prediction.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Regulatory_and_Price_Cap_Risk\"><\/span><strong>Regulatory and Price Cap Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Government-mandated price caps on medical procedures affect hospital revenues and can compress the Dr Lal PathLabs stock forecast.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Competition\"><\/span><strong>Competition<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>New hospital chains expanding into metro and tier 2 cities create competitive pressure on occupancy and billing, which is a recurring caution in the Dr Lal PathLabs share price prediction.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Medical_Cost_Inflation\"><\/span><strong>Medical Cost Inflation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Rising manpower and consumables costs affect EBITDA margins and the Dr Lal PathLabs stock forecast. Cost risk is reflected in the width of the Dr Lal PathLabs share price prediction range.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Monitor_the_Dr_Lal_PathLabs_Stock_Forecast\"><\/span><strong>How to Monitor the Dr Lal PathLabs Stock Forecast<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Track the Dr Lal PathLabs share price prediction consensus quarterly. After every earnings release, most brokerages revise their Dr Lal PathLabs stock forecast within two weeks. Comparing the revised Dr Lal PathLabs stock prediction to the previous estimate tells you whether analyst sentiment is improving or deteriorating.<\/p>\n<p>Compare the current price of Rs 1,591.3 with the analyst target range of Rs 1800 to Rs 1750. A wide Dr Lal PathLabs stock prediction band reflects genuine uncertainty, so position size should reflect that range rather than the midpoint alone.<\/p>\n<p>Review the Dr Lal PathLabs share price prediction every quarter against key business metrics for the Healthcare Services and Hospitals sector. A single estimate from any analyst is a point-in-time view and should be treated as one input among many when making any investment decision.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\" target=\"_blank\" rel=\"noopener\">Check Live Dr Lal PathLabs Fundamentals on the Univest Screener<\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Dr Lal PathLabs stock prediction for 2026 reflects the analyst community&#8217;s assessment of Dr Lal PathLabs&#8217;s competitive position, earnings trajectory and macro environment. JM Financial holds a Neutral stance with a target of Rs 1800 while ICICI Securities has a Neutral rating with a target of Rs 1750, giving an analyst consensus of Rs 1775.<\/p>\n<p>The Dr Lal PathLabs stock forecast is set against near-term risks that make the Dr Lal PathLabs share price prediction range wide. Investors should verify any estimate with the latest brokerage reports before using it as an investment reference. The analyst forecast will be revised after every quarterly result, so tracking changes in the Dr Lal PathLabs stock prediction over time is more valuable than relying on any single estimate.<\/p>\n<p><em>Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.<\/em><\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stock-advisor-broker\/id1559167021\" target=\"_blank\" rel=\"noopener nofollow\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.app\" target=\"_blank\" rel=\"noopener nofollow\">Univest Android App<\/a> to track the live Dr Lal PathLabs stock prediction and share price prediction changes in real time.<\/em><\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information and may or may not be accurate. Analyst price targets are from public brokerage reports and should be independently verified. Please verify all data with the official NSE (<a style=\"color: #ffcccc;\" href=\"https:\/\/www.nseindia.com\" rel=\"nofollow noopener\" target=\"_blank\">nseindia.com<\/a>) and BSE (<a style=\"color: #ffcccc;\" href=\"https:\/\/www.bseindia.com\" rel=\"nofollow noopener\" target=\"_blank\">bseindia.com<\/a>) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Dr_Lal_PathLabs_Stock_Prediction_2026\"><\/span><strong>Frequently Asked Questions on Dr Lal PathLabs Stock Prediction 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Dr_Lal_PathLabs_stock_prediction_for_2026\"><\/span><strong>What is the Dr Lal PathLabs stock prediction for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Dr Lal PathLabs stock prediction for 2026 is based on analyst consensus from JM Financial and ICICI Securities. The consensus target is Rs 1775. All estimates may or may not be achieved.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_the_Dr_Lal_PathLabs_stock_prediction_bullish_or_bearish\"><\/span><strong>Is the Dr Lal PathLabs stock prediction bullish or bearish?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> JM Financial has a Neutral rating with target Rs 1800. ICICI Securities has a Neutral rating with target Rs 1750. The Dr Lal PathLabs stock forecast reflects genuine analyst diversity of opinion.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Dr_Lal_PathLabs_share_price_prediction_based_on_fundamentals\"><\/span><strong>What is the Dr Lal PathLabs share price prediction based on fundamentals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Dr Lal PathLabs share price prediction rests on the bed addition pipeline, occupancy trend, revenue per bed and EBITDA margin maturity. Analysts tracking Dr Lal PathLabs closely cite these as the primary drivers of the 2026 outlook.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_long-term_Dr_Lal_PathLabs_stock_prediction\"><\/span><strong>What is the long-term Dr Lal PathLabs stock prediction?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The long-term Dr Lal PathLabs stock prediction assumes the company sustains its core business drivers over a multi-year horizon. The 12-month consensus of Rs 1775 is the nearest reliable anchor point.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_to_the_Dr_Lal_PathLabs_stock_prediction\"><\/span><strong>What are the key risks to the Dr Lal PathLabs stock prediction?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The primary risks include sector-specific headwinds, macro uncertainty, regulatory changes and competitive pressure. Every Dr Lal PathLabs stock prediction should be read alongside its risk assumptions.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_the_Dr_Lal_PathLabs_stock_forecast_say_for_2026\"><\/span><strong>What does the Dr Lal PathLabs stock forecast say for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> JM Financial: Neutral target Rs 1800. ICICI Securities: Neutral target Rs 1750. These Dr Lal PathLabs share price prediction estimates may or may not prove accurate.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_the_latest_Dr_Lal_PathLabs_stock_prediction\"><\/span><strong>Where can I track the latest Dr Lal PathLabs stock prediction?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Track the latest Dr Lal PathLabs stock prediction on the NSE and BSE websites and on the Univest app and screener for live price and updated analyst targets.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the Dr Lal PathLabs stock prediction for 2026?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Dr Lal PathLabs stock prediction for 2026 is based on analyst consensus from JM Financial and ICICI Securities. The consensus target is Rs 1775. All estimates may or may not be achieved.\"}},{\"@type\":\"Question\",\"name\":\"Is the Dr Lal PathLabs stock prediction bullish or bearish?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"JM Financial has a Neutral rating with target Rs 1800. ICICI Securities has a Neutral rating with target Rs 1750. The Dr Lal PathLabs stock forecast reflects genuine analyst diversity of opinion.\"}},{\"@type\":\"Question\",\"name\":\"What is the Dr Lal PathLabs share price prediction based on fundamentals?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Dr Lal PathLabs share price prediction rests on the bed addition pipeline, occupancy trend, revenue per bed and EBITDA margin maturity. Analysts tracking Dr Lal PathLabs closely cite these as the primary drivers of the 2026 outlook.\"}},{\"@type\":\"Question\",\"name\":\"What is the long-term Dr Lal PathLabs stock prediction?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The long-term Dr Lal PathLabs stock prediction assumes the company sustains its core business drivers over a multi-year horizon. The 12-month consensus of Rs 1775 is the nearest reliable anchor point.\"}},{\"@type\":\"Question\",\"name\":\"What are the key risks to the Dr Lal PathLabs stock prediction?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The primary risks include sector-specific headwinds, macro uncertainty, regulatory changes and competitive pressure. Every Dr Lal PathLabs stock prediction should be read alongside its risk assumptions.\"}},{\"@type\":\"Question\",\"name\":\"What does the Dr Lal PathLabs stock forecast say for 2026?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"JM Financial: Neutral target Rs 1800. ICICI Securities: Neutral target Rs 1750. These Dr Lal PathLabs share price prediction estimates may or may not prove accurate.\"}},{\"@type\":\"Question\",\"name\":\"Where can I track the latest Dr Lal PathLabs stock prediction?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Track the latest Dr Lal PathLabs stock prediction on the NSE and BSE websites and on the Univest app and screener for live price and updated analyst targets.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Dr Lal PathLabs stock prediction 2026 from leading analysts. JM Financial: Neutral Rs 1800. Full Dr Lal PathLabs stock forecast for Healthcare Services and H&#8230;<\/p>\n","protected":false},"author":35,"featured_media":114381,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-113024","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1781163375:26"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["71"],"rank_math_focus_keyword":["Dr Lal PathLabs Stock Prediction 2026"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Dr Lal PathLabs Stock Prediction 2026: Forecast and Analysis"],"rank_math_description":["Dr Lal PathLabs stock prediction 2026 from leading analysts. Full Dr Lal PathLabs stock forecast, bull bear scenarios and Dr Lal PathLabs share price predict..."],"_wp_old_date":["2026-06-10"],"_thumbnail_id":["114381"],"_edit_last":["26"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["17193"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/06\/Dr-Lal-PathLabs-Stock-Prediction-2026.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/113024","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=113024"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/113024\/revisions"}],"predecessor-version":[{"id":114382,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/113024\/revisions\/114382"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/114381"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=113024"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=113024"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=113024"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}